Wave Life Sciences (WVE) Other Working Capital Changes (2016 - 2026)
Wave Life Sciences (WVE) has disclosed Other Working Capital Changes for 12 consecutive years, with $4.8 million as the latest value for Q1 2026.
- For Q1 2026, Other Working Capital Changes rose 152.64% year-over-year to $4.8 million; the TTM value through Mar 2026 reached $9.7 million, up 223.57%, while the annual FY2025 figure was -$4.3 million, 1072.28% down from the prior year.
- Other Working Capital Changes hit $4.8 million in Q1 2026 for Wave Life Sciences, up from -$1.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $102.5 million in Q2 2023 and bottomed at -$104.8 million in Q3 2023.
- Average Other Working Capital Changes over 5 years is -$74470.6, with a median of $802000.0 recorded in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 3238.57% in 2023 and fell as far as 9389.04% in 2023.
- Wave Life Sciences' Other Working Capital Changes stood at $109000.0 in 2022, then surged by 2100.0% to $2.4 million in 2023, then surged by 354.34% to $10.9 million in 2024, then plummeted by 113.06% to -$1.4 million in 2025, then soared by 439.42% to $4.8 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods came in at $4.8 million, -$1.4 million, and $802000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.